SASINEE BHOSAI: Open Payments
NPI 1033691316 · GLENDORA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,305 in 29 payments from 8 companies in 2025. Trend: 2023 $2,036 · 2024 $969 · 2025 $1,305
Food & beverage: $1,200Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $474 |
| Alkermes, Inc. | 8 | $268 |
| Axsome Therapeutics, Inc. | 4 | $200 |
| Otsuka America Pharmaceutical, Inc. | 3 | $164 |
| ABBVIE INC. | 4 | $62 |
| Janssen Pharmaceuticals, Inc | 2 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: UZEDY, Auvelity, REXULTI, ARISTADA, LYBALVI, AUSTEDO XR, VRAYLAR, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
